Abstract
Lesch-Nyhan disease is a debilitating disorder caused by a lack of purine salvage activity. Basal ganglia dopamine deficits manifest in both patients and hypoxanthine phosphoribosyltransferase (HPRT) mutant mice. We previously reported decreased activity in an oxidant sensitive enzyme in the brain of HPRT-deficient mice. In the present study, we have investigated whether one source of free radicals, neuronal nitric oxide synthase (NOS1), contributes to the dopamine deficit associated with HPRT deficiency. HPRT knockout and wild-type mice were bred, either to lack, or to have the full complement of NOS1 alleles. Double mutant mice had striatal dopamine and dopamine metabolite levels indistinguishable from the HPRT single mutant counterparts. These results indicate that NOS1 produced nitric oxide does not contribute to the dopamine deficit seen in HPRT deficiency.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Ara J, Przedborski S, Naini AB, Jackson-Lewis V, Trifiletti R, Horwitz J, Ischiropoulos H (1998) Inactivation of tyrosine hydroxylase by nitration following exposure to peroxynitrite and 1-mthyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP). Proc Natl Acad Sci USA 95(13):7659–7663
Ernst M, Zametkin AJ, Matochik JA, Pascualvaca D, Jons PH, Hardy K, Hankerson JG, Doudet DJ, Cohen RM (1996) Presynaptic dopaminergic deficits in Lesch-Nyhan disease. NEJM 334(24):1568–1572
Gardner P (2002) Aconitase: Sensitive target and measure of superoxide. Methods Enzymol 349:9–23
Hantraye P, Brouillet E, Ferrante R, Palfi S, Dolan R, Matthews RT, Beal MF (1996) Inhibition of neuronal nitric oxide synthase prevents MPTP-induced parkinsonism in baboons. Nat Med 2(3):1017–1021
He Y, Imam S, Dong Z, Jankovic J, Ali S, Appel S, Le W (2003) Role of nitric oxide in rotenone-induced nigro-striatal injury. J Neurochem 86(6):1338–1345
Huang P, Dawson T, Bredt D, Snyder S, Fishman M (1993) Targeted disruption of the neuronal nitric oxide synthase gene. Cell 75(7):1273–1286
Hunot S, Hirsch E (2003) Neuroinflammatory processes in Parkinson’s disease. Ann Neurol 53(Suppl 3):S49–S60
Itzhak Y, Ali S (1996) The neuronal nitric oxide synthase inhibitor, 7-nitroindazole, protects against methamphetamine-induced neurotoxicity. J Neurochem 67(4):1770–1773
Jenner P (2003) Oxidative stress in Parkinson’s disease. Ann Neurol 53(Suppl 3):S26–S38
Jinnah H, Friedmann T (2001) Lesch-Nyhan disease and its variants. In: Scriver C, Beaudet A, Valle D, Sly W (eds) The metabolic and molecular bases of inherited disease. McGraw Hill. II:2537–2570
Jinnah H, Jones M, Wojcik B, Rothstein J, Hess E, Friedmann T, Breese G (1999) Influence of age and strain on striatal dopamine loss in a genetic mouse model of Lesch-Nyhan disease. J Neurochem 72:225–229
Jinnah HA, De Gregorio L, Harris JC, Nyhan WL, O’Neill JP (2000) The spectrum of inherited mujtations causing HPRT deficiency: 75 new cases and a review of 196 previously reported cases. Mutat Res 463:309–326
Jinnah HA, Hess E, Wilson M, Gage F, Friedmann T (1992) Localization of hypoxanthine-guanine phosphoribosyltransferase mRNA in the mouse brain by in situ hybridization. Mol Cell Neurosci 3:64–78
Jinnah HA, Wojcik B, Hunt M, Narang N, Lee K, Goldstein M, Wamsley JK, Langlais P, Friedmann T (1994) Dopamine deficiency in a genetic mouse model of Lesch-Nyhan disease. J Neurosci 14(3):1164–1175
Lloyd K, Hornykiewicz O, Davidson L, Shannak K, Farley I, Goldstein M, Shibuya M, Kelley W, Fox I (1981) Biochemical evidence of dysfunction of brain neurotransmitters in the Lesch-Nyhan syndrome. New Eng J Med 5:1106–1111
Przedborski S, Jackson-Lewis V, Yokoyama R, Shibata T, Dawson VL, Dawson KM (1996) Role of neuronal nitric oxide in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced dopaminergic neurotoxicity. Proc Natl Acad Sci, USA 93:4565–4571
Rosenbloom F, Henderson J, Caldwell L, Kelley W, Seegmiller J (1968) Biochemical basis of accelerated purine biosynthesis de novo in human fibroblasts lacking hypoxanthine-guanine phosphoribosyltransferase. J Biol Chem 243(6):1166–1173
Visser JE, Smith DW, Moy SS, Breese GR, Friedmann T, Rothstein JD, Jinnah HA (2002) Oxidative stress and dopamine deficiency in a genetic mouse model of Lesch-Nyhan disease. Dev Brain Res 133:127–139
Wong D, Harris JC, Naidu S, Yokoi F, Marenco S, Dannals R, Ravert H, Yaster M, Evans A, Rousset O, Bryan R, Gjedde A, Kuhar M, Breese G (1996) Dopamine transporters are markedly reduced in Lesch-Nyhan disease in vivo. Proc Natl Acad Sci, USA 93:5539–5543
Acknowledgements
This work was supported by funding from the Lesch-Nyhan Children’s Research Foundation and NIH (NS44544-0IAI).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Smith, D.W., Jinnah, H.A. Role of Neuronal Nitric Oxide in the Dopamine Deficit of HPRT-Deficient Mice. Metab Brain Dis 22, 39–43 (2007). https://doi.org/10.1007/s11011-007-9044-7
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11011-007-9044-7